306 related articles for article (PubMed ID: 18463319)
21. Realgar, cinnabar and An-Gong-Niu-Huang Wan are much less chronically nephrotoxic than common arsenicals and mercurials.
Lu YF; Wu Q; Yan JW; Shi JZ; Liu J; Shi JS
Exp Biol Med (Maywood); 2011 Feb; 236(2):233-9. PubMed ID: 21321321
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide: safety issues and their management.
Au WY; Kwong YL
Acta Pharmacol Sin; 2008 Mar; 29(3):296-304. PubMed ID: 18298894
[TBL] [Abstract][Full Text] [Related]
23. Bioactive poly(arsenic) compounds.
Mancini I; Defant A
Prog Mol Subcell Biol; 2013; 54():175-95. PubMed ID: 24420714
[TBL] [Abstract][Full Text] [Related]
24. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
25. [Research progress in mineral Chinese medicine realgar].
Song LL; Han DY; Lin RC; Huang JM; Guan J
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(3):433-440. PubMed ID: 30989904
[TBL] [Abstract][Full Text] [Related]
26. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
[TBL] [Abstract][Full Text] [Related]
27. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.
Shen ZX; Chen GQ; Ni JH; Li XS; Xiong SM; Qiu QY; Zhu J; Tang W; Sun GL; Yang KQ; Chen Y; Zhou L; Fang ZW; Wang YT; Ma J; Zhang P; Zhang TD; Chen SJ; Chen Z; Wang ZY
Blood; 1997 May; 89(9):3354-60. PubMed ID: 9129042
[TBL] [Abstract][Full Text] [Related]
28. Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1.
Xu W; Chen Z; Shen X; Pi C
Iran J Immunol; 2019 Jun; 16(2):170-181. PubMed ID: 31182691
[TBL] [Abstract][Full Text] [Related]
29. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
Rojewski MT; Körper S; Schrezenmeier H
Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
[TBL] [Abstract][Full Text] [Related]
31. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells.
Song P; Hai Y; Wang X; Zhao L; Chen B; Cui P; Xie Q; Yu L; Li Y; Wu Z; Li H
Arch Pharm Res; 2018 Apr; 41(4):467-480. PubMed ID: 29542005
[TBL] [Abstract][Full Text] [Related]
32. Comparing the relative oxidative DNA damage caused by various arsenic species by quantifying urinary levels of 8-hydroxy-2'-deoxyguanosine with isotope-dilution liquid chromatography/mass spectrometry.
Wu JZ; Ho PC
Pharm Res; 2009 Jun; 26(6):1525-33. PubMed ID: 19266267
[TBL] [Abstract][Full Text] [Related]
33. [Speciation analysis and toxicity of arsenic in realgar bioleaching solution].
Zhang JH; Fan Q; Li HY
Zhong Yao Cai; 2010 May; 33(5):684-8. PubMed ID: 20873549
[TBL] [Abstract][Full Text] [Related]
34. Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia.
Au WY; Tam S; Fong BM; Kwong YL
Blood; 2006 Apr; 107(7):3012-3. PubMed ID: 16554490
[No Abstract] [Full Text] [Related]
35. [Arsenic speciation in rat plasma after oral administration of realgar and Niu Huang Jie Du Pian].
Zhang YJ; Qiang SP; Song M; Hang TJ
Yao Xue Xue Bao; 2016 Jul; 51(7):1130-5. PubMed ID: 29897219
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
Huan SY; Yang CH; Chen YC
Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
[TBL] [Abstract][Full Text] [Related]
37. Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats.
Chen C; Zhang BB; Hu AL; Li H; Liu J; Zhang F
J Ethnopharmacol; 2020 Jan; 247():112299. PubMed ID: 31606537
[TBL] [Abstract][Full Text] [Related]
38. [Toxicokinetics and tissue distribution study of arsenic in realgar].
Zhang J; Tang Y; Liu Q
Zhongguo Zhong Yao Za Zhi; 2010 Jul; 35(13):1750-3. PubMed ID: 20862972
[TBL] [Abstract][Full Text] [Related]
39. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
Du YH; Ho PC
Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
[TBL] [Abstract][Full Text] [Related]
40. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
